Marinomed Biotech AG Announces Second Capital Increase

Marinomed Biotech AG, based in Korneuburg, Austria, has announced a second capital increase. The company will issue 83,750 new no-par value bearer shares, priced at EUR 8 per share. This move will increase the company's share capital by EUR 83,750, bringing it to a total of EUR 1,778,333.

This capital increase excludes statutory subscription rights and has been approved by the Management Board. The new shares will be offered to nine selected investors, raising a total of EUR 670,000. The decision follows previous announcements regarding potential capital increases made in September and November 2024.

The Supervisory Board's approval is pending, and the necessary resolutions will follow, respecting regulatory procedures. This step highlights Marinomed's ongoing strategies to strengthen its financial base.